Add this event to your calendar
The IEC–IPC Eczema and Psoriasis Research Incubator is a pre-congress, interactive forum designed to catalyze cross-disciplinary collaboration and accelerate innovation across inflammatory skin diseases. Featuring keynote presentations from global thought leaders, the program moves from cutting-edge insights into disease mechanisms and precision stratification to data-driven, translational approaches that inform real-world practice. Participants will engage in rapid-fire early-career presentations and structured small-group “Challenge Labs” focused on priority research themes, with the goal of identifying actionable gaps and shaping collaborative project concepts. This highly interactive format emphasizes practical outcomes, new partnerships, and sustained engagement beyond the session. Early-career investigators are strongly encouraged to apply.
Registration for the ESDR Congress is required to attend the IEC-IPC Program on Wednesday, September 9, 2026.
Agenda
Registration and Breakfast
Welcome & Framing Remarks
Sara J. Brown, MD, PhD, FRCPE, FRSE, Scotland and Curdin Conrad, MD, Switzerland
KEYNOTE: From Mechanism to Precision: Defining Disease Endotypes
Johann Gudjonsson, MD, PhD, United States
KEYNOTE: From Data to Impact: Translating Evidence into Practice
Satveer Mahil, PhD, FRCP, United Kingdom
Lightning Talks: Early-Career Investigator Spotlights
- Proteomic Signatures of Cardiovascular Risk Are Amplified in Psoriasis: A UK Biobank Proteomics Study – Ravi Ramessur, MD, PhD, United Kingdom
- Atopic Dermatitis–Psoriasis Overlap: From Clinical Phenotypes to Therapeutic Strategies – Mengmeng Li, MD, PhD, China
- Evolutionary Variation in the ERAP1-HLA Pathway and Psoriasis Susceptibility – Akiko Arakawa, MD, PhD, Germany
- Untangling the Web: A Systems-Based Approach at Single-Cell Resolution Reveals Druggable Targets in Atopic Dermatitis – Tara Urselmann, MSc, Netherlands
- Targeting Dysfunctional Endothelial Cells in Psoriasis – Matt Vesely, MD, PhD, United States
BREAK
Challenge Labs: Small Group Innovation Sessions
- Shared Comorbidities – Facilitators: Anna López-Ferrer, MD, PhD, Spain and Caroline Mann, MD, Germany
- Mechanisms of Disease – Facilitators: Claus Johansen, MSc, PhD, DMSc, Denmark and Danuta Gutowska-Owsiak, MD, PhD, DSc, Poland
- Endotypes – Facilitators: Paola Di Meglio, PhD, United Kingdom and Mari Løset, MD, PhD, Norway
- Treatment Stratification – Facilitators: Andreas Pinter, MD, PhD, Germany and Nick Reynolds, BSc, MBBS, MD, FRCP, United Kingdom
- Precision Medicine – Facilitators: Nicole Ward, PhD, United States and John Common, PhD, United Kingdom
- Paradoxical Cases – Facilitators: Johann Gudjonsson, MD, PhD, United States and Satveer Mahil, PhD, FRCP, United Kingdom
- Global Challenges – Facilitator: Chris Griffiths, OBE, MD, FMedSci, United Kingdom
Small Group Reflections & Expert Commentary Panel
Closing Reflections & Next Steps
Program Chairs
Johann Gudjonsson, MD, PhD
University of Michigan, Department of Dermatology
Ann Arbor, Michigan, United States
IPC Board Member
Nicole Ward, PhD
Vanderbilt University Medical Center and Vanderbilt University
Nashville, Tennessee, United States
IPC Councilor
Program Faculty
Christopher Griffiths, OBE, MD, FMedSci
University of Manchester and King’s College London
London, United Kingdom
IPC Honorary Founder
Mari Løset, MD, PhD
Norwegian University of Science and Technology and St. Olavs Hospital, Trondheim University Hospital
Trondheim, Norway
IPC Councilor
Nick Reynolds, BSc, MBBS, MD, FRCP
Newcastle University
Newcastle upon Tyne, United Kingdom
IPC Councilor
This program is supported in part by
